Skip to content

ACADIA 制药

US · ACAD #2404 按市值排名 上市于 1970
19.12 -0.59 -2.99%
实时 - 追踪5344个代码 - 心跳于531秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

涨跌不一/平稳
  • 机构持股总比例基本持平。

机构持股

机构持股比例
98.93% +0.00pp
机构数量
425
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund51.74%
Hedge Fund40.97%
Public Company2.20%
Government Pension Fund1.07%
VC/PE Fund0.97%
Sovereign Wealth Fund0.97%
Individual/Insider0.55%
Insurance Company0.49%
Private Company0.43%
Other0.60%

主要股东 截至 2026-06-30

Baker Bros. Advisors LP 24.91% · 42.91M 股
BlackRock 13.07% · 22.52M 股
State Street Global Advisors 5.27% · 9.08M 股
Vanguard Portfolio Management, LLC 5.13% · 8.84M 股
RTW Investments, LP 4.15% · 7.14M 股
Vanguard Capital Management, LLC 3.87% · 6.68M 股
Dimensional Fund Advisors 2.14% · 3.69M 股
Geode Capital Management, LLC 1.95% · 3.36M 股
Palo Alto Investors LP 1.66% · 2.86M 股
Qube Research & Technologies Ltd 1.42% · 2.45M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 36次买入 · 14次卖出

姓名职务持股比例
Baker Bros. Advisors LP -- 24.91%
Stephen Davis Chief Executive Officer 0.26%
Julian Baker Independent Director 0.06%
Mark Schneyer Chief Financial Officer 0.04%
Daniel Soland Independent Director 0.03%
Edmund Harrigan Independent Director 0.03%
Elizabeth Garofalo Independent Director 0.02%
Adora Ndu Independent Director 0.02%
Laura Brege Independent Director 0.01%
Elizabeth H. Thompson Executive VP & Head of Research and Development 0.01%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-08-05 Mark Schneyer Chief Financial Officer Derivative Exercise and Sale -20,141 $17.84–29.34
2026-08-04 Mark Schneyer Chief Financial Officer Intent to Sell (Form 144) -5,849 $27.15
2026-07-29 Elizabeth H. Thompson Executive VP & Head of Research and Development Derivative Exercise and Sale -16,558 $26.13–26.17
2026-07-28 Elizabeth H. Thompson Executive VP & Head of Research and Development Derivative Exercise and Retained +15,714 --
2026-06-25 James Kihara VP, Chief Accounting Officer & Corporate Controller Automatic Disposition -11,421 $26.08
2026-05-28 Laura Brege Independent Director Other Derivative Acquisition +9,311 --
2026-05-28 Laura Brege Independent Director Other Derivative Acquisition +16,004 $21.66
2026-05-28 Laura Brege Independent Director Derivative Exercise and Retained +8,107 --
2026-05-28 Julian Baker Independent Director Other Derivative Acquisition +64,016 $21.66
2026-05-28 Edmund Harrigan Independent Director Other Derivative Acquisition +9,311 --
2026-05-28 Edmund Harrigan Independent Director Other Derivative Acquisition +16,004 $21.66
2026-05-28 Edmund Harrigan Independent Director Derivative Exercise and Retained +8,107 --
2026-05-28 James Daly Independent Director Other Derivative Acquisition +9,311 --
2026-05-28 James Daly Independent Director Other Derivative Acquisition +16,004 $21.66
2026-05-28 James Daly Independent Director Derivative Exercise and Retained +8,107 --
2026-05-28 Baker Bros. Advisors LP -- Other Acquisition +37,244 --
2026-05-28 Jonathan Poole Director Other Derivative Acquisition +9,311 --
2026-05-28 Jonathan Poole Director Other Derivative Acquisition +16,004 $21.66
2026-05-28 Jonathan Poole Director Derivative Exercise and Retained +2,010 --
2026-05-28 Adora Ndu Independent Director Other Derivative Acquisition +9,311 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

ACADIA 制药 讨论区 0 条评论

发表评论